Evidence map›Paper›PMID 39955516›Full record

ArticleBMC microbiology2025

Prevalence and characterization of class I integrons in multidrug-resistant Escherichia coli isolates from humans and food-producing animals in Zhejiang Province, China.

Han Jiang, Meijuan Ran, Xinyuan Wang, Qi Chen, Jing Wang, Zhi Ruan, Jingwen Wang, Biao Tang, Jiehong Fang

Abstract read
In one paragraph

Article in BMC microbiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Mutation analysis of dihydrofolate reductase (Iranian journal of microbiology · 2026
    Article
  3. Article
  4. Article
  5. Review
  6. Strategic Detection ofBiosensors · 2025
    Review
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Han Jiang *Key Laboratory of Specialty Agri-products Quality and Hazard Controlling Technology of Zhejiang Province, College of Life Sciences, China Jiliang University, Hangzhou, 310018, Zhejiang, China.
Meijuan Ran *Key Laboratory of Specialty Agri-products Quality and Hazard Controlling Technology of Zhejiang Province, College of Life Sciences, China Jiliang University, Hangzhou, 310018, Zhejiang, China.
Xinyuan WangHangzhou Institute for Food and Drug Control, Hangzhou, 310022, Zhejiang, China.
Qi ChenKey Laboratory of Specialty Agri-products Quality and Hazard Controlling Technology of Zhejiang Province, College of Life Sciences, China Jiliang University, Hangzhou, 310018, Zhejiang, China.
Jing WangZhejiang Gongzheng Testing Center Co., Ltd, Hangzhou, 310000, Zhejiang, China.
Zhi RuanDepartment of Clinical Laboratory, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou, 310016, Zhejiang, China.
Jingwen WangKey Laboratory of Specialty Agri-products Quality and Hazard Controlling Technology of Zhejiang Province, College of Life Sciences, China Jiliang University, Hangzhou, 310018, Zhejiang, China.
Biao TangKey Laboratory of Systems Health Science of Zhejiang Province, School of Life Science, Hangzhou Institute for Advanced Study, University of Chinese Academy of Sciences, Hangzhou, 310024, Zhejiang, China. tangbiao@ucas.ac.cn.
Jiehong FangKey Laboratory of Specialty Agri-products Quality and Hazard Controlling Technology of Zhejiang Province, College of Life Sciences, China Jiliang University, Hangzhou, 310018, Zhejiang, China. fangjh@cjlu.edu.cn.

Funding

the Fundamental Research Funds for the Provincial Universities of Zhejiang 2023YW13the 'Leading Goose' R&D Program of Zhejiang Province 2023C03045the National Natural Science Foundation of China 32472452the National Natural Science Foundation of China 32472292the Natural Science Foundation of Zhejiang Province LZ25C200001Zhejiang Provincial Natural Science Foundation of China LY23C180001
6 · The paper itself

Abstract

Class I integrons have garnered significant attention due to pivotal roles in the dissemination of antimicrobial resistance genes (ARGs), which impose risks to public health and food safety. Here, the prevalence and characteristics of class I integrons in Escherichia coli isolates derived from food-producing animals and human patients were assessed. Of 721 E. coli isolates collected from human patients (113), pigs (298), and poultry (310), 93 (12.90%) carried the class I integrase gene (intI1). Multilocus sequence typing identified 39 sequence types from 93 intI1-postive isolates, including three novel types. Sequence analysis revealed that 59 classical class I integrons encompassed six distinct gene cassettes arrangements [dfrA17-aadA5, dfrA12-aadA2, dfrA1-aadA1, dfrA7, aac(6')-Ib, and aadA1-aac(3)-VIa]. Six insertion sequences (IS1, IS6, IS21, IS91, IS110, and IS256) and one transposon (Tn3) were harbored in proximity to the integrons. A comparison with sequences retrieved from the National Center for Biotechnology Information database demonstrated that E. coli isolates with integron sequences were detected in various food-producing animals and human hosts in environmental niches across Asia, Europe, and North America. These findings indicate the potential risk of ARG transmission between food-producing animals and humans by bacteria populations and provide useful baseline data for monitoring of ARGs.

Indexed as

Drug Resistance, Multiple, BacterialEscherichia coliEscherichia coli InfectionsIntegronsAnimalsAnti-Bacterial AgentsChinaDNA, BacterialEscherichia coli ProteinsFood MicrobiologyHumansIntegrasesMicrobial Sensitivity TestsMultilocus Sequence TypingPoultryPrevalenceAnti-Bacterial AgentsDNA, BacterialEscherichia coli ProteinsIntegrasesClass I integronsFood-producing animalsGene cassettesHuman patientsMultidrug-resistant Escherichia coli

Identifiers

PMID39955516
PMCPMC11830211

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.